Sanguine Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 119

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 22

Sanguine General Information

Description

Developer of a translational biomedical and biospecimen collection platform designed for research purposes. The company's platform offers direct-to-patient engagement, in-home collection of annotated biospecimens, and apheresis product offerings, enabling researchers to access and conduct prospective study designs and obtain clinically relevant biomarker data.

Contact Information

Website
www.sanguinebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 West Cummings Park
  • Suite 3050
  • Woburn, MA 01801
  • United States
+1 (855)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Discovery Tools (Healthcare)
Vertical(s)
Digital Health, SaaS, HealthTech, Life Sciences
Corporate Office
  • 400 West Cummings Park
  • Suite 3050
  • Woburn, MA 01801
  • United States
+1 (855)

Sanguine Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanguine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 15-Aug-2024 Completed Generating Revenue
10. Debt - General 31-Oct-2023 Completed Generating Revenue
9. Later Stage VC 09-Jan-2023 Completed Generating Revenue
8. Secondary Transaction - Private 16-Mar-2022 Completed Generating Revenue
7. Debt - PPP 08-Apr-2020 Completed Generating Revenue
6. Grant 01-Feb-2019 Completed Generating Revenue
5. Accelerator/Incubator 18-Mar-2018 Completed Generating Revenue
4. Later Stage VC 01-Jul-2016 Completed Generating Revenue
3. Later Stage VC (Series A) 29-May-2015 $5.53M $7.03M Completed Startup
2. Seed Round 21-Feb-2013 $1.5M $1.5M Completed Startup
To view Sanguine’s complete valuation and funding history, request access »

Sanguine Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Sanguine’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sanguine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a translational biomedical and biospecimen collection platform designed for research purposes. The company'
Other Healthcare Technology Systems
Woburn, MA
119 As of 2024

Austin, TX
 

Salt Lake City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sanguine Competitors (2)

One of Sanguine’s 2 competitors is Asuragen, a Formerly VC-backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Asuragen Formerly VC-backed Austin, TX
Myriad Genetics Corporation Salt Lake City, UT
You’re viewing 2 of 2 competitors. Get the full list »

Sanguine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sanguine Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Albany Capital (Australia) Venture Capital Minority
BroadOak Capital Partners Growth/Expansion Minority
Catalio Capital Management Venture Capital Minority
Vitamin Capital Venture Capital Minority
Neman Ventures Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

Ready to get started?

Request a free trial

Sanguine FAQs

  • When was Sanguine founded?

    Sanguine was founded in 2010.

  • Where is Sanguine headquartered?

    Sanguine is headquartered in Woburn, MA.

  • What is the size of Sanguine?

    Sanguine has 119 total employees.

  • What industry is Sanguine in?

    Sanguine’s primary industry is Other Healthcare Technology Systems.

  • Is Sanguine a private or public company?

    Sanguine is a Private company.

  • What is Sanguine’s current revenue?

    The current revenue for Sanguine is .

  • How much funding has Sanguine raised over time?

    Sanguine has raised $27.5M.

  • Who are Sanguine’s investors?

    Albany Capital (Australia), BroadOak Capital Partners, Catalio Capital Management, Vitamin Capital, and Neman Ventures are 5 of 22 investors who have invested in Sanguine.

  • Who are Sanguine’s competitors?

    Asuragen and Myriad Genetics are competitors of Sanguine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »